Alterations in gastric acidity in patients infected with human Immunodeficiency virus

Clinical Infectious Diseases

Volumn 21, Issue 6, 1995, Pages 1431-1438

  Welage, Lynda S ^a,b,c   Carver, Peggy L ^a,b,c   Revankar, Sanjay ^a,b,c   Pierson, Carl ^a,b,c   Kauffman, Carol A ^a,b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; PENTAGASTRIN;

ARTICLE; CANCER RISK; CANDIDA ALBICANS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTESTINE FLORA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STOMACH PH;

EID: 0029561243     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/21.6.1431     Document Type: Article

References (28)

1. Dworkin B, Wormser GP, Rosenthal WS, et al. Gastrointestinal manifestations of the acquired immunodeficiency syndrome: a review of 22 cases. Am J Gastroenterol 1985;80:774-8.
2. Ullrich R, Zeitz M, Heise W, L’age M, Hoffken G, Riecken EO. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med 1989;111:15-21.
3. Kotler DP, Gaetz HP, Lange M, Kein EB, Holt PR. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984;101:421-8.
4. Lake-Bakaar G, Quadros E, Beidas S, et al. Gastric secretory failure in patients with acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988;109:502-4.
5. Belitsos PC, Greenson JK, Yardley JH, Sisler JR, Bartlett JG. Association of gastric hypoacidity with opportunistic enteric infections in patients with AIDS. J Infect Dis 1992; 166:277-84.
6. Lake-Bakaar G, Tom W, Lake-Bakaar D, et al. Gastropathy and ketocona- zole malabsorption in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988;109:471-3.
7. Van Tyle HJ. Ketoconazole: mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy 1984;4:343-73.
8. Knapp MJ, Berardi RR, Dressman JB, Rider JM, Carver PL. Modification of gastric pH with oral glutamic acid hydrochloride. Clinical Pharmacy 1991;10:866-9.
9. Giorgi JV, Detels R. T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort study. Clin Immunol Immunopa- thol 1989;52:10-8.
10. Nightingale SD, Jockusch JD, Haslund I, Cal SX, Peterson DM, Loss SD. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection. Arch Intern Med 1993; 153:1313-8.
11. Fasman GD, ed. Handbook of biochemistry and molecular biology: physical and chemical data section. 3rd ed. Boca Raton, Florida: CRC Press, 1973:354.
12. Balows A, Hausler WH, Heimann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. Washington, DC: American Society for Microbiology, 1991.
13. Richardson CT. Peptic ulcer: pathogenesis. In: Wyngaarden JB, Smith LH, eds. Cecil textbook of medicine. 18th ed. Philadelphia: WB Saunders, 1988.
14. Herzlich BC, Schiano TD, Moussa Z, Zimbalist E, Panagopoulous G, Nawabi I. Decreased intrinsic factor secretion in AIDS: relation to parietal cell secretory capacity and vitamin B12 malabsorption. Am J Gastroenterol 1992;87:1781-8.
15. Shaffer RT, LaHatte LJ, Kelly JW, et al. Gastric acid secretion in HIV infection. Am J Gastroenterol 1992;87:1777-80.
16. Dressman JB, Berardi RR, Dermentzoglou LC, et al. Upper gastrointestinal (GI) pH in young healthy men and women. Pharm Res 1990; 7: 56-61.
17. Welage LS, Berardi RR. Drug interactions with antiulcer agents: considerations in the treatment of acid peptic disease. J Pharm Pract 1994; 7: 77-95.
18. Pounder RE, Fraser AG. Gastric acid secretion and intragastric acidity: measurement in health and disease. Baillieres Clin Gastroenterol 1993;7:55-80.
19. Lim SG, Sayerr AM, Hudson M, et al. Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity. Aliment Pharmacol Ther 1993;7:317-21.
20. Saathoff N, Lode H, Neider K, et al. Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist. Antimicrob Agents Chemother 1992;36:796-800.
21. Lebsack ME, Nix D, Ryerson B, et al. Effect of gastric acidity on enoxacin absorption. Clin Pharmacol Ther 1992;52:252-6.
22. Grasela TH, Schentag JJ, Sedman AJ, et al. Inhibition of enoxacin absorption by antacids or ranitidine. Antimicrob Agents Chemother 1989;33:615-7.
23. Brady CE, Hadfield TL, Hyatt JR, Utts SJ. Acid secretion and serum gastrin levels in individuals with Campylobacter pylori. Gastroenterology 1988;94:923-7.
24. Rune S. Helicobacter pylori, peptic ulcer disease and inhibition of gastric acid secretion. Digestion 1992;51:11-6.
25. Ruggero B, Raviglione MC, Palagiano A, et al. Helicobacter pylori infection in patients with acquired immunodeficiency syndrome. Am J Gastroenterol 1990;85:1576-9.
26. Heatley RV, Sobala GM. Acid suppression and gastric flora. Baillieres Clin Gastroenterol 1993;7:167-81.
27. Hillman KM, Riordan T, O’Farrell SM, et al. Colonization of the gastric contents in critically ill patients. Crit Care Med 1982; 10(7):444.
28. Donowitz LG, Page MC, Mileur BL, et al. Alteration of normal gastric flora in critical care patients receiving antacid and cimetidine therapy. Infect Control 1986; 7:23.